These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9682709)

  • 21. Long-term metabolic control and retinopathy in type I diabetes: ten-year follow-up.
    Giansanti R; Boemi M; Amodio L; Fioravanti P; Rabini RA; Fumelli P
    Diabetes Res; 1994; 25(2):77-84. PubMed ID: 7648782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinopathy in patients with type 1 diabetes 4 years after intensive therapy.
    Bressler SB; Bressler NM
    Arch Ophthalmol; 2000 Jul; 118(7):984-5. PubMed ID: 10910526
    [No Abstract]   [Full Text] [Related]  

  • 23. Does tight control of systemic factors help in the management of diabetic retinopathy?
    Rajalakshmi R; Prathiba V; Mohan V
    Indian J Ophthalmol; 2016 Jan; 64(1):62-8. PubMed ID: 26953026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversion of 'early worsening' of diabetic retinopathy by deliberate restoration of poor metabolic control.
    Chantelau E; Meyer-Schwickerath R
    Ophthalmologica; 2003; 217(5):373-7. PubMed ID: 12913330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study.
    Hadjadj S; Péan F; Gallois Y; Passa P; Aubert R; Weekers L; Rigalleau V; Bauduceau B; Bekherraz A; Roussel R; Dussol B; Rodier M; Marechaud R; Lefebvre PJ; Marre M;
    Diabetes Care; 2004 Nov; 27(11):2661-8. PubMed ID: 15505002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood glucose control and microvascular complications--what do we do now?
    Dahl-Jørgensen K; Brinchmann-Hansen O; Bangstad HJ; Hanssen KF
    Diabetologia; 1994 Dec; 37(12):1172-7. PubMed ID: 7895945
    [No Abstract]   [Full Text] [Related]  

  • 27. Glycated hemoglobin A1C level and the risk of diabetic retinopathy in Africa: A systematic review and meta-analysis.
    Shiferaw WS; Akalu TY; Desta M; Kassie AM; Petrucka PM; Assefa HK; Aynalem YA
    Diabetes Metab Syndr; 2020; 14(6):1941-1949. PubMed ID: 33039936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus.
    Klein R; Klein BE; Moss SE
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):90-6. PubMed ID: 8554220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strict metabolic control and retinal blood flow in diabetes mellitus.
    Grunwald JE; Brucker AJ; Braunstein SN; Schwartz SS; Baker L; Petrig BL; Riva CE
    Br J Ophthalmol; 1994 Aug; 78(8):598-604. PubMed ID: 7918284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
    Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
    Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring contrast sensitivity in aretinopathic patients with Insulin Dependent Diabetes Mellitus.
    De Marco R; Capasso L; Magli A; Franzese A; Gasparini N; Ambrosio G
    Doc Ophthalmol; 1996-1997; 93(3):199-209. PubMed ID: 9550348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The longest ever randomised controlled trial of insulin glargine: study design and HbA(1c) findings.
    Currie CJ
    Diabetologia; 2009 Oct; 52(10):2234-5; author reply 2236-9. PubMed ID: 19662377
    [No Abstract]   [Full Text] [Related]  

  • 33. Glycaemic control and control of risk factors in diabetes patients in an ophthalmology clinic: what lessons have we learned from the UKPDS and DCCT studies?
    Higgins GT; Khan J; Pearce IA
    Acta Ophthalmol Scand; 2007 Nov; 85(7):772-6. PubMed ID: 17944626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.
    Kitzmiller JL; Main E; Ward B; Theiss T; Peterson DL
    Diabetes Care; 1999 May; 22(5):874-6. PubMed ID: 10332713
    [No Abstract]   [Full Text] [Related]  

  • 35. Cotherapy with recombinant human IGF-I and insulin improves glycemic control in type 1 diabetes.
    Lanzetta P; Malara C
    Diabetes Care; 2000 Mar; 23(3):436-7. PubMed ID: 10868894
    [No Abstract]   [Full Text] [Related]  

  • 36. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Aiello LP;
    Diabetes Care; 2014; 37(1):17-23. PubMed ID: 24356593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes.
    Sartore G; Chilelli NC; Burlina S; Lapolla A
    Acta Diabetol; 2013 Jun; 50(3):437-42. PubMed ID: 23417155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early worsening of diabetic retinopathy due to intensive glycaemic control.
    Lim SW; van Wijngaarden P; Harper CA; Al-Qureshi SH
    Clin Exp Ophthalmol; 2019 Mar; 47(2):265-273. PubMed ID: 30238577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
    Rosenstock J; Fonseca V; McGill JB; Riddle M; Hallé JP; Hramiak I; Johnston P; Davis M
    Diabetologia; 2009 Sep; 52(9):1778-88. PubMed ID: 19526210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
    Hirsch IB
    Diabetes Care; 2015 Aug; 38(8):1610-4. PubMed ID: 26207054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.